Unraveling the fertility knot in World Health Organization type 2 anovulatory women Another step toward a pharmacogenetic treatment choice
Reflections on “FSH receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (WHO2) anovulatory infertility” by Valkenburg et al.
Published
Authors
Manuela Simoni, M.D., Ph.D.
Volume 103, Issue 4, Pages 900-901
Abstract
Reflections on “FSH receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (WHO2) anovulatory infertility” by Valkenburg et al.
Read the full text at: http://www.fertstert.org/article/S0015-0282(15)00085-0/fulltext
